“While most of us are not excited about CYDY spe
Post# of 148187
(Total Views: 299)
Posted On: 05/13/2019 10:38:47 AM
“While most of us are not excited about CYDY spending more money of preclinical trials at this point, I'm sure they would not do so without good reasoning..”
The reasoning for CYDY starting this preclinical trial is the due to the past success of Maraviroc. Like NP said last week or a few weeks ago, they’re going to follow in the foot steps of Maraviroc, specifically with indications that Maraviroc showed success in. We know that Maraviroc has showed promise for various indications but it’s side effects limit the drugs use. Preclinical trials aren’t too expensive and are a good way of expanding the pipeline potential and value of CYDY. The mice in the Maraviroc trial were tested after 16 weeks for efficacy show it will be 4-5 months until we hear about the results.
The reasoning for CYDY starting this preclinical trial is the due to the past success of Maraviroc. Like NP said last week or a few weeks ago, they’re going to follow in the foot steps of Maraviroc, specifically with indications that Maraviroc showed success in. We know that Maraviroc has showed promise for various indications but it’s side effects limit the drugs use. Preclinical trials aren’t too expensive and are a good way of expanding the pipeline potential and value of CYDY. The mice in the Maraviroc trial were tested after 16 weeks for efficacy show it will be 4-5 months until we hear about the results.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼